In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

The study predicts that an additional 3.3 million children and teens and another 3.4 million young adults will be overweight ...

As more Americans are prescribed weight loss drugs like Ozempic and Wegovy following celebrity endorsements, people who depend on such medications have struggled to access them. Sarah Sostak, a ...

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and ...

In a little over two decades, almost 260 million people in the United States are predicted to have overweight or obesity, ...